544067 logo

Innova Captab BSE:544067 Stock Report

Last Price

₹927.90

Market Cap

₹52.9b

7D

-7.6%

1Y

76.3%

Updated

07 Feb, 2025

Data

Company Financials +

544067 Stock Overview

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. More details

544067 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance5/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Innova Captab Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Innova Captab
Historical stock prices
Current Share Price₹927.90
52 Week High₹1,259.00
52 Week Low₹421.55
Beta0
1 Month Change-21.86%
3 Month Change-2.37%
1 Year Change76.32%
3 Year Changen/a
5 Year Changen/a
Change since IPO70.21%

Recent News & Updates

Recent updates

Shareholder Returns

544067IN Life SciencesIN Market
7D-7.6%4.8%1.6%
1Y76.3%49.5%5.5%

Return vs Industry: 544067 exceeded the Indian Life Sciences industry which returned 49.5% over the past year.

Return vs Market: 544067 exceeded the Indian Market which returned 5.5% over the past year.

Price Volatility

Is 544067's price volatile compared to industry and market?
544067 volatility
544067 Average Weekly Movement8.9%
Life Sciences Industry Average Movement6.7%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 544067's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 544067's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
20051,600Vinay Lohariwalainnovacaptab.com

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals.

Innova Captab Limited Fundamentals Summary

How do Innova Captab's earnings and revenue compare to its market cap?
544067 fundamental statistics
Market cap₹52.94b
Earnings (TTM)₹1.27b
Revenue (TTM)₹11.92b

41.6x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544067 income statement (TTM)
Revenue₹11.92b
Cost of Revenue₹7.91b
Gross Profit₹4.01b
Other Expenses₹2.73b
Earnings₹1.27b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)22.26
Gross Margin33.63%
Net Profit Margin10.69%
Debt/Equity Ratio29.2%

How did 544067 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 20:35
End of Day Share Price 2025/02/07 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Innova Captab Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Abdulkader PuranwalaICICI Securities Ltd.
Amey ChalkeJM Financial Institutional Securities Limited